SCHEMBL3471124

SCHEMBL3471124

CCN1C(=O)C(=CC=Cc2ccco2)C(=O)NC1=S

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 16/20 0.80
KMT2A Q03164 16/20 0.80
MAPT P10636 14/20 0.80
RECQL P46063 14/20 0.80
POLB P06746 10/20 0.80
ALDH1A1 P00352 8/20 0.80
L3MBTL1 Q9Y468 7/20 0.80
HPGD P15428 5/20 0.80
APEX1 P27695 3/20 0.80
THRB P10828 2/20 0.80
TDP1 Q9NUW8 2/20 0.80
NSD2 O96028 2/20 0.80
ALOX12 P18054 1/20 0.80
DNMT1 P26358 1/20 0.80
MCL1 Q07820 1/20 0.80
DUSP3 P51452 1/20 0.76
KDM4E B2RXH2 3/20 0.73
ALPL P05186 1/20 0.73
ALPI P09923 1/20 0.73
ALPG P10696 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14712984 1.00 MEN1 (0.80) MEN1KMT2AMAPTRECQLPOLB
SCHEMBL3471120 1.00 MEN1 (0.80) MEN1KMT2AMAPTRECQLPOLB
SCHEMBL14712893 0.89 MEN1 (0.74) MEN1KMT2AMAPTRECQLPOLB
SCHEMBL16542997 0.86 DUSP3 (1.00) MEN1KMT2AMAPTRECQLPOLB
SCHEMBL14712947 0.84 MEN1 (1.00) MEN1KMT2AMAPTRECQLPOLB
SCHEMBL14713067 0.84 MEN1 (0.81) MEN1KMT2AMAPTRECQLPOLB
SCHEMBL14712869 0.81 BCL2A1 (0.61) MEN1KMT2AMAPTRECQLPOLB
SCHEMBL14712995 0.81 BCL2A1 (0.61) MEN1KMT2AMAPTRECQLPOLB
SCHEMBL14712966 0.78 KMT2A (0.51) MEN1KMT2AMAPTRECQLPOLB
SCHEMBL14712882 0.78 MEN1 (0.51) MEN1KMT2AMAPTRECQLPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9211296-B2 Therapeutic compounds for blocking DNA synthesis of POX viruses THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2015-12-15 US disclosed
US-20130338117-A1 THERAPEUTIC COMPOUNDS FOR BLOCKING DNA SYNTHESIS OF POX VIRUSES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2013-12-19 US disclosed
US-8524719-B2 Therapeutic compounds for blocking DNA synthesis of pox viruses THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2013-09-03 US disclosed
US-20120322770-A1 THERAPEUTIC COMPOUNDS FOR BLOCKING DNA SYNTHESIS OF POX VIRUSES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-12-20 US disclosed
US-8278342-B2 Therapeutic compounds for blocking DNA synthesis of pox viruses THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2012-10-02 US disclosed
US-20100035887-A1 THERAPEUTIC COMPOUNDS FOR BLOCKING DNA SYNTHESIS OF POX VIRUSES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322770-A1 THERAPEUTIC COMPOUNDS FOR BLOCKING DNA SYNTHESIS OF POX VIRUSES TPX2, POLB, POLM MEN1 4101/4885KMT2A 3300/4885MAPT 4220/4885
US-20100035887-A1 THERAPEUTIC COMPOUNDS FOR BLOCKING DNA SYNTHESIS OF POX VIRUSES TPX2, POLB, POLM MEN1 4101/4885KMT2A 3300/4885MAPT 4220/4885
US-20130338117-A1 THERAPEUTIC COMPOUNDS FOR BLOCKING DNA SYNTHESIS OF POX VIRUSES TPX2, POLB, POLM MEN1 4101/4885KMT2A 3300/4885MAPT 4220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.